FDA Warns About Johnson & Johnson COVID Vaccine and Guillain-Barré Syndrome Risk—Here's What That Means
Of the 100 preliminary reports of Guillain-Barré syndrome, 95 were serious.
Of the 100 preliminary reports of Guillain-Barré syndrome, 95 were serious.